La Jolla, CA, United States of America

Julie M Cherrington

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Phenomix Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julie M Cherrington. Retrieved from https://idiyas.com/inventor/julie-m-cherrington

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Julie M Cherrington

Introduction

Julie M Cherrington is a notable inventor based in La Jolla, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of DPP-IV inhibitors. Her work has led to advancements that are crucial for managing certain medical conditions.

Latest Patents

Julie holds a patent for "Solid tartrate salts of DPP-IV inhibitors." This invention pertains to DPP-IV inhibitory citrate or tartrate salts of pyrrolidinylaminoacetyl pyrrolidine boronic acid compounds. These compounds are characterized as physically and chemically stable, and they are substantially non-deliquescent solids under ambient conditions. This innovation is essential for enhancing the efficacy and stability of DPP-IV inhibitors.

Career Highlights

Julie is currently associated with Phenomix Corporation, where she continues to work on innovative solutions in the pharmaceutical industry. Her expertise and dedication have positioned her as a key figure in her field.

Collaborations

Throughout her career, Julie has collaborated with esteemed colleagues, including Zhen-Ping Wu and David Alan Campbell. These partnerships have fostered a collaborative environment that encourages innovation and progress.

Conclusion

Julie M Cherrington's contributions to the field of pharmaceuticals through her patent on DPP-IV inhibitors exemplify her commitment to innovation. Her work continues to impact the industry positively, showcasing the importance of research and development in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…